Bio+Tech
We have a great respect for nature. By using deep technology to amplify its gifts we are creating a
disruptive multi cancer early detection test.
Sensitive. When it really
matters.
Spotitearly is currently conducting a large clinical trial for screening breast, lung, colon and prostate
cancers in
one test. During training phase, our test showed higher sensitivity and better specificity in
detecting early stages of cancer compared to any existing test on the market today. Stay tuned.
We are Spotitearly
We, a group of passionate multidisciplinary experts with a century of experience between us in AI,
biology, medicine, zoology, business and operations, came together to accomplish this (ultra)
important mission.
